VERO — Venus Concept Share Price
Last trade - 00:00- $97.49m
- $160.24m
- $78.01m
- 33
- 47
- 31
- 32
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.48 | ||
| Price to Tang. Book | 8.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.99 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -24.03% | ||
| Return on Equity | -104.88% | ||
| Operating Margin | -26.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 15.6 | 21.3 | 21.96 | 110.41 | 78.01 | 105 | 126.45 | 35.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Venus Concept Inc. is a global medical technology company. It develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Its hair restoration division includes NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a Follicular unit extraction (FUE) process and the ARTAS and ARTAS iX Robotic Hair Restoration Systems, which harvests follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The Company operates in the United States, Canada, United Kingdom, Japan, South Korea, Mexico, Argentina, Colombia, Spain, France, Germany, Australia, China, Hong Kong, and Israel.
Directors
- Scott Barry NEC (48)
- Domenic Serafino CEO (60)
- Domenic Penna CFO (59)
- Ross Portaro CEX
- Soren Sinay COO (50)
- Melissa Kang VPR (54)
- Anna Georgiadis VPR (50)
- Yoni Iger VRD (61)
- Keith Sullivan DRC (61)
- Garheng Kong IND (45)
- Louise Lacchin IND (63)
- Fritz LaPorte IND (51)
- Anthony Natale IND (47)
- Last Annual
- December 31st, 2020
- Last Interim
- September 30th, 2021
- Incorporated
- November 22nd, 2002
- Public Since
- October 12th, 2017
- No. of Shareholders
- 143
- No. of Employees
- 384
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 54,162,629
- Address
- 235 Yorkland Blvd Suite 900, TORONTO, M2J 4Y8
- Web
- https://www.venusconcept.com/en-uk/
- Phone
- +1 4088836888
- Contact
- Mike Piccinino
- Auditors
- MNP LLP
Latest News for VERO
Upcoming Events for VERO
Venus Concept Inc Annual Shareholders Meeting
Similar to VERO
908 Devices.
NASDAQ Global Market
Alpha Teknova
NASDAQ Global Market
Apollo Endosurgery
NASDAQ Global Market
AtriCure
NASDAQ Global Market
Aziyo Biologics
NASDAQ Global Market
FAQ
As of Today at 19:01 UTC, shares in Venus Concept are trading at $1.80. This share price information is delayed by 15 minutes.
Shares in Venus Concept last closed at $1.80 and the price had moved by -19.28% over the past 365 days. In terms of relative price strength the Venus Concept share price has underperformed the S&P500 Index by -34.72% over the past year.
The overall consensus recommendation for Venus Concept is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Venus Concept does not currently pay a dividend.
Venus Concept does not currently pay a dividend.
Venus Concept does not currently pay a dividend.
To buy shares in Venus Concept you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.80, shares in Venus Concept had a market capitalisation of $97.49m.
Here are the trading details for Venus Concept:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: VERO
Based on an overall assessment of its quality, value and momentum Venus Concept is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Venus Concept is $5.31. That is 195% above the last closing price of $1.80.
Analysts covering Venus Concept currently have a consensus Earnings Per Share (EPS) forecast of -$0.44 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Venus Concept. Over the past six months, its share price has underperformed the S&P500 Index by -32.85%.
As of the last closing price of $1.80, shares in Venus Concept were trading -13.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Venus Concept PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Venus Concept's management team is headed by:
- Scott Barry - NEC
- Domenic Serafino - CEO
- Domenic Penna - CFO
- Ross Portaro - CEX
- Soren Sinay - COO
- Melissa Kang - VPR
- Anna Georgiadis - VPR
- Yoni Iger - VRD
- Keith Sullivan - DRC
- Garheng Kong - IND
- Louise Lacchin - IND
- Fritz LaPorte - IND
- Anthony Natale - IND